No Data
No Data
No Data
No Data
No Data
Looking At AstraZeneca's Recent Unusual Options Activity
Financial giants have made a conspicuous bearish move on AstraZeneca. Our analysis of options history for AstraZeneca (NASDAQ:AZN) revealed 12 unusual trades.Delving into the details, we found 16% of
Benzinga15minutes ago
Tech Advances Are Catalyzing the Health Care Sector With Improved Investor Sentiment - SSGA
Seeking Alpha14:48 ET
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
Drug shortages in the UK have more than doubled between 2020 and 2023, a recent study by the Nuffield Trust reveals. Brexit is cited as a significant factor exacerbating the country's struggle to mana
BenzingaApr 19 11:39 ET
Astrazeneca (AZN) Could Be a Great Choice
Yahoo FinanceApr 18 11:45 ET
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
Tuesday, Amgen Inc (NASDAQ:AMGN) provided an update regarding the results of the Phase 2a COURSE trial for Tezspire (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD). Tezspire is a re
BenzingaApr 17 14:39 ET
AstraZeneca (AZN.US) TOPAZ-1 III clinical study doubles OS in patients with advanced biliary tract cancer
On April 16, AstraZeneca (AZN.US) announced the latest exploratory analysis results of the phase 3 clinical trial TOPAZ-1.
Zhitong FinanceApr 17 08:49 ET
Strike freedom : Don’t have akebia?
MeltyyOP Strike freedom: the first of the post
Strike freedom MeltyyOP: I mean in the April calendar
Srav Reddy : Wonder why $Akebia Therapeutics (AKBA.US)$ dropped after PDUFA
No Data
No Data